如何通过骨髓和外周血涂片诊断酸性鞘磷脂酶缺乏症(ASMD)和尼曼-皮克病 C 型。

IF 7.6 2区 医学 Q1 HEMATOLOGY HemaSphere Pub Date : 2024-11-05 DOI:10.1002/hem3.70042
Sandrine Girard, Magali Pettazzoni, Roseline Froissart, Cécile Pagan, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Catherine Trichet, Lucile Baseggio, on behalf the French-Speaking Cellular Haematology Group (GFHC)
{"title":"如何通过骨髓和外周血涂片诊断酸性鞘磷脂酶缺乏症(ASMD)和尼曼-皮克病 C 型。","authors":"Sandrine Girard,&nbsp;Magali Pettazzoni,&nbsp;Roseline Froissart,&nbsp;Cécile Pagan,&nbsp;Thomas Boyer,&nbsp;Stephanie Dulucq,&nbsp;Valérie Gonçalves Monteiro,&nbsp;Nicolas Lechevalier,&nbsp;Marie Loosveld,&nbsp;Camille Lours,&nbsp;Caroline Mayeur-Rousse,&nbsp;Mélanie Pannetier,&nbsp;Caroline Peillon,&nbsp;Maria-Alessandra Rosenthal,&nbsp;Sonnthida Sep Hieng,&nbsp;Catherine Trichet,&nbsp;Lucile Baseggio,&nbsp;on behalf the French-Speaking Cellular Haematology Group (GFHC)","doi":"10.1002/hem3.70042","DOIUrl":null,"url":null,"abstract":"<p>Lysosomal storage diseases (LSD) are inborn errors of metabolism disorders characterized by a defect in a lysosomal enzyme, transporter, or cofactor. Niemann–Pick diseases are classified into two distinct disorders: acid sphingomyelinase deficiency (ASMD) historically known as Niemann–Pick disease types A, AB, and B, and Niemann-Pick disease type C (NPC).<span><sup>1</sup></span> ASMD is a rare autosomal recessive LSD, caused by pathogenic variants in the ASM-encoding <i>SMPD1</i> gene (OMIM#607608).<span><sup>2</sup></span> It results in the accumulation of sphingomyelin and other lipids, primarily in the liver, spleen, lung, bone marrow, lymph nodes, and central nervous system.<span><sup>3</sup></span> Depending on their clinical phenotype, three different subtypes have been reported: A (severe infantile neurovisceral form), AB (chronic neurovisceral form), and B (chronic visceral form), with a continuum spectrum.<span><sup>1-4</sup></span> NPC is an autosomal recessive LSD caused by the defective function of one of two proteins, NPC1 or NPC2. It results from mutations in the corresponding genes (OMIM#257220 and OMIM#607625). These two proteins act in sequence to regulate the egress of endocytosed nonesterified cholesterol from the late endosomal/lysosomal compartment. NPC manifests as a neurovisceral disease with a highly heterogeneous clinical spectrum.<span><sup>5</sup></span> The prognosis of NPC is correlated with the age of onset of neurological symptoms, with four neurological forms defined: early infantile, late infantile, juvenile, and adolescent-adult. The diagnosis of ASMD and NPC is difficult because these diseases are heterogeneous and may share clinical features with other LSD such as Gaucher disease, especially when splenomegaly is present.<span><sup>5</sup></span> Some cytological abnormalities have been reported in bone marrow (BM) and peripheral blood (PB) smears from ASMD and NPC patients, which could help to guide the more specific analysis such as enzymatic activity, biomarkers measurement, and genetic testing.<span><sup>6</sup></span> However, the cytological data available in the literature are rather limited, often described in single case reports, and do not distinguish the different forms of ASMD and NPC. This work aims to report the cytological features of BM and PB in a retrospective study of 30 French cases from 28 families with ASMD types A [<i>n</i> = 5], AB [<i>n</i> = 3], B [<i>n</i> = 16], and NPC [<i>n</i> = 6], to improve knowledge and define recommendations to assist in diagnosis.</p><p>The diagnosis of cases was based on biochemical analysis, specifically either a deficiency in acid sphingomyelinase activity in blood and/or an abnormal plasma biomarkers profile (i.e., lysosphingomyelin, lysosphingomyelin509/<i>N</i>-palmitoyl-O-phosphocholineserine, and oxysterols), confirmed by specific gene analysis, except for two suspected NPC patients for whom the genetic study was inconclusive and identified a variant of uncertain significance.<span><sup>7</sup></span> Of the 30 cases, 18 were analyzed at diagnosis (10 BM with corresponding PB, 4 BM only, and 4 PB only) and 12 during follow-up, including 9 treated patients (11 PB and 1 BM with corresponding PB). The median age at diagnosis was 8 months (range 6.0–13.0) for ASMD A, 18.0 years for ASMD AB, 53 years (range 20–87.0 months) for ASMD B, and 11.0 years (range 2.0–17.0) for NPC. The male-to-female ratios is 2:3, 1:0, 8:1, and 3:0, respectively.</p><p>Two experienced cytologists (SG, LB) reviewed the cytological features of BM and PB smears following staining with May Grünwald-Giemsa under double-blind conditions using a light microscope. They assessed leukocyte and histiocyte/macrophage characteristics as well as the pattern of the hematopoietic tissue.</p><p>Examination of 14 diagnostic BM smears (Table 1A and Figure 1A) revealed numerous foamy histiocytes (FH) in all cases (ASMD and NPC) often clustered and sometimes isolated. Their nuclei were round or oval, occasionally eccentric, and rarely bi-nucleated. The cytoplasm was abundant, containing numerous small white vacuoles of various sizes, which were highlighted in blue or pink. In some cases, emperipolesis and histiocytes with iron deposits or debris (resembling small black or dark blue beads) were observed. Seven cases exhibited sea-blue histiocytes (SBH), predominantly ASMD B and one in ASMD AB (Figure 1Aa). Vacuolization of hematopoietic cells was observed in three cases, including one case in which vacuolated lymphocytes (VL) were also present in PB (Figure 1Ab). In six cases, adipose vacuoles were more numerous in the spreads, or fatty inclusions were observed in the hematopoietic tissue (Figure 1Ac). Qualitative abnormalities such as dysmyelopoiesis were not noted.</p><p>Examination of 26 PB smears (14 at diagnosis and 12 at follow-up) (Tables 1A,B and Figure 1B) revealed six diagnostic cases with VL exceeding the 5% positivity threshold recommended by the GFHC (5 ASMD A and 1 NPC).<span><sup>6</sup></span> VL exhibited a small number of empty vacuoles (ranging from 2 to 10) with regular contours, often clustered at one pole of the cell (morula-like) or aligned in a manner reminiscent of pearls on a string; they were rarely found in isolation (Figure 1B). In two cases, associated BM smears were analyzed, and only one showed vacuolated cells, including lymphocytes (Figure 1A case 5). No VL was identified in less severe forms at diagnosis (ASMD AB, B and later-onset NPC) or in patients followed at a distance from diagnosis (ASMD AB under enzyme replacement therapy (ERT) [<i>n</i> = 2 siblings], ASMD B ERT treated [<i>n</i> = 4] or untreated [<i>n</i> = 3], and NPC treated [<i>n</i> = 3]).</p><p>When splenomegaly and/or cytopenia are detected, a BM examination is often scheduled. Cytological analysis of BM and PB smears provides valuable information for diagnosing hematological disorders and aids in identifying certain rare LSD. Abnormal accumulation of metabolic by-products within lysosomes may result in the observation of storage cells (large histiocytic storage cells or VL) in BM and PB smears, as well as in prenatal effusions.<span><sup>7</sup></span> Identifying these storage cells can be challenging for untrained observers, as they may resemble storage cells from other LSD or appear similar to reactive cells.</p><p>In BM samples, the primary lesion was characterized by variable proportions of FH and, occasionally, SBH, as described in the literature.<span><sup>1, 9</sup></span> Despite the limited number of cases studied, SBH were primarily identified in patients with ASMD B and one patient with ASMD AB (Table 1A patient 10). SBH were not exclusive and were consistently found in conjunction with non-blue FH. This distinctive cytological appearance is also observed in various other LSD, including gangliosides, ceroid lipofuscinosis, and acquired diseases such as hemoglobinopathies (thalassemia, sickle cell anemia), neoplasms (chronic myeloid leukemia, lymphoma), immunological disorders (idiopathic thrombocytopenic purpura, chronic septic granulomatosis), or lipid storage disorders (SBH syndrome, parenteral nutrition). Interestingly, in patients 2 and 3, the presence of FH guided the diagnosis of LSD in the context of splenomegaly. In these two cases, the NPC biomarker profile was abnormal, but genetic testing did not confirm the diagnosis of NPC. Both patients were found to be compound heterozygous for a pathogenic or likely pathogenic variant and a variant of uncertain significance in the <i>NPC1</i> gene. The clinical significance of variants <i>NPC1</i>:p.Asn222Ser and p.Ser1004Leu is currently debated in the literature and among experts (see ClinVar database). However, these two cases illustrate that such variants, when combined with a pathogenic or likely pathogenic variant, may be associated with hematological manifestations. The densities of SBH and FH were variable and did not correlate with age; this variation appeared to be more related to the cell density of the smear.</p><p>Moreover, analysis of the BM smears revealed that approximately 50% of them exhibited a high lipid content, accompanied by a multitude of adipose vacuoles. No correlation was identified between the patient's lipid profile (when available), age, or disease type, and the proportion of lipid-laden histiocytes. This aspect was more closely related to the quality of the slides, as those that were diluted were less lipid-rich. Cytopenias, particularly thrombocytopenia, are common in patients with ASMD or NPC.<span><sup>1, 5, 10</sup></span> A review of complete blood count results revealed no correlation between the depth or presence of cytopenias and the proportion of BM infiltration by storage histiocytes.</p><p>In PB, VL is not often described in ASMD patients, contrary to NPC or other LSD.<span><sup>11</sup></span> Interestingly, only neurological forms of ASMD (type A) and NPC presented VL in our series. To our knowledge, no cases of ASMD B with VL in PB have been reported in the literature. Distinguishing these VL from reactive lymphocytes present in PB during an infectious episode is crucial.<span><sup>12</sup></span> The latter also display cytoplasmic microvacuoles, which can be observed as a small number of dispersed, fine vacuoles (ranging from one to three in number), or as a multitude of very fine vacuoles, irregularly distributed throughout the cytoplasm, with no discernible order or structure.</p><p>In conclusion, an increased number of FH with white and/or pale blue inclusions is a feature of BM smears in all types of ASMD/NPC. The detection of these FH (which is not limited to SBH alone) represents a significant advancement in the cytological diagnostic approach to ASMD/NPC. The identification of SBH strongly suggests an ASMD type B diagnosis, which requires confirmation by enzymatic activity measurement in combination with <i>SMPD1</i> gene analysis. In contrast, the presence of circulating VL in both PB and BM is uncommon in ASMD and NPC cases. Their presence should prompt consideration of a LSD, particularly a severe form with neurological involvement such as ASMD A or infantile NPC forms. This study represents the largest case series to date, and the results are noteworthy. Further investigation is required in a large prospective study. Finally, a meticulous examination of BM and PB smears is an essential tool to assist in the diagnosis of ASMD and NPC. This analysis is a valuable tool that can help define the different types of ASMD, in addition to the clinical examination and molecular analysis.</p><p>Sandrine Girard and Lucile Baseggio were involved in conceptualization, methodology, collecting data, analysis data, and writing of the original draft preparation. Sandrine Girard, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Catherine Trichet provided cases. Sandrine Girard, Mélanie Pannetier, Roseline Froissart, Cécile Pagan, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Lucile Baseggio were involved in reviewing the manuscript.</p><p>The authors declare no conflict of interest.</p><p>The study was approved by the Biological Resources Center policy of the Hospices Civils de Lyon. The procedures followed were in accordance with the Declaration of Helsinki. The protocol received approval from the institutional review board (DC-24-5447) This manuscript respects the ethical policy of Hospices Civils de Lyon for the treatment of human research participants. The authors did not obtain written informed consent from the patients but the patients did not object to their data being used for research purposes (as required by the ethics policy of Hospices Civils de Lyon).</p><p>This research received no funding.</p>","PeriodicalId":12982,"journal":{"name":"HemaSphere","volume":"8 11","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538321/pdf/","citationCount":"0","resultStr":"{\"title\":\"How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann–Pick disease type C from bone marrow and peripheral blood smears\",\"authors\":\"Sandrine Girard,&nbsp;Magali Pettazzoni,&nbsp;Roseline Froissart,&nbsp;Cécile Pagan,&nbsp;Thomas Boyer,&nbsp;Stephanie Dulucq,&nbsp;Valérie Gonçalves Monteiro,&nbsp;Nicolas Lechevalier,&nbsp;Marie Loosveld,&nbsp;Camille Lours,&nbsp;Caroline Mayeur-Rousse,&nbsp;Mélanie Pannetier,&nbsp;Caroline Peillon,&nbsp;Maria-Alessandra Rosenthal,&nbsp;Sonnthida Sep Hieng,&nbsp;Catherine Trichet,&nbsp;Lucile Baseggio,&nbsp;on behalf the French-Speaking Cellular Haematology Group (GFHC)\",\"doi\":\"10.1002/hem3.70042\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Lysosomal storage diseases (LSD) are inborn errors of metabolism disorders characterized by a defect in a lysosomal enzyme, transporter, or cofactor. Niemann–Pick diseases are classified into two distinct disorders: acid sphingomyelinase deficiency (ASMD) historically known as Niemann–Pick disease types A, AB, and B, and Niemann-Pick disease type C (NPC).<span><sup>1</sup></span> ASMD is a rare autosomal recessive LSD, caused by pathogenic variants in the ASM-encoding <i>SMPD1</i> gene (OMIM#607608).<span><sup>2</sup></span> It results in the accumulation of sphingomyelin and other lipids, primarily in the liver, spleen, lung, bone marrow, lymph nodes, and central nervous system.<span><sup>3</sup></span> Depending on their clinical phenotype, three different subtypes have been reported: A (severe infantile neurovisceral form), AB (chronic neurovisceral form), and B (chronic visceral form), with a continuum spectrum.<span><sup>1-4</sup></span> NPC is an autosomal recessive LSD caused by the defective function of one of two proteins, NPC1 or NPC2. It results from mutations in the corresponding genes (OMIM#257220 and OMIM#607625). These two proteins act in sequence to regulate the egress of endocytosed nonesterified cholesterol from the late endosomal/lysosomal compartment. NPC manifests as a neurovisceral disease with a highly heterogeneous clinical spectrum.<span><sup>5</sup></span> The prognosis of NPC is correlated with the age of onset of neurological symptoms, with four neurological forms defined: early infantile, late infantile, juvenile, and adolescent-adult. The diagnosis of ASMD and NPC is difficult because these diseases are heterogeneous and may share clinical features with other LSD such as Gaucher disease, especially when splenomegaly is present.<span><sup>5</sup></span> Some cytological abnormalities have been reported in bone marrow (BM) and peripheral blood (PB) smears from ASMD and NPC patients, which could help to guide the more specific analysis such as enzymatic activity, biomarkers measurement, and genetic testing.<span><sup>6</sup></span> However, the cytological data available in the literature are rather limited, often described in single case reports, and do not distinguish the different forms of ASMD and NPC. This work aims to report the cytological features of BM and PB in a retrospective study of 30 French cases from 28 families with ASMD types A [<i>n</i> = 5], AB [<i>n</i> = 3], B [<i>n</i> = 16], and NPC [<i>n</i> = 6], to improve knowledge and define recommendations to assist in diagnosis.</p><p>The diagnosis of cases was based on biochemical analysis, specifically either a deficiency in acid sphingomyelinase activity in blood and/or an abnormal plasma biomarkers profile (i.e., lysosphingomyelin, lysosphingomyelin509/<i>N</i>-palmitoyl-O-phosphocholineserine, and oxysterols), confirmed by specific gene analysis, except for two suspected NPC patients for whom the genetic study was inconclusive and identified a variant of uncertain significance.<span><sup>7</sup></span> Of the 30 cases, 18 were analyzed at diagnosis (10 BM with corresponding PB, 4 BM only, and 4 PB only) and 12 during follow-up, including 9 treated patients (11 PB and 1 BM with corresponding PB). The median age at diagnosis was 8 months (range 6.0–13.0) for ASMD A, 18.0 years for ASMD AB, 53 years (range 20–87.0 months) for ASMD B, and 11.0 years (range 2.0–17.0) for NPC. The male-to-female ratios is 2:3, 1:0, 8:1, and 3:0, respectively.</p><p>Two experienced cytologists (SG, LB) reviewed the cytological features of BM and PB smears following staining with May Grünwald-Giemsa under double-blind conditions using a light microscope. They assessed leukocyte and histiocyte/macrophage characteristics as well as the pattern of the hematopoietic tissue.</p><p>Examination of 14 diagnostic BM smears (Table 1A and Figure 1A) revealed numerous foamy histiocytes (FH) in all cases (ASMD and NPC) often clustered and sometimes isolated. Their nuclei were round or oval, occasionally eccentric, and rarely bi-nucleated. The cytoplasm was abundant, containing numerous small white vacuoles of various sizes, which were highlighted in blue or pink. In some cases, emperipolesis and histiocytes with iron deposits or debris (resembling small black or dark blue beads) were observed. Seven cases exhibited sea-blue histiocytes (SBH), predominantly ASMD B and one in ASMD AB (Figure 1Aa). Vacuolization of hematopoietic cells was observed in three cases, including one case in which vacuolated lymphocytes (VL) were also present in PB (Figure 1Ab). In six cases, adipose vacuoles were more numerous in the spreads, or fatty inclusions were observed in the hematopoietic tissue (Figure 1Ac). Qualitative abnormalities such as dysmyelopoiesis were not noted.</p><p>Examination of 26 PB smears (14 at diagnosis and 12 at follow-up) (Tables 1A,B and Figure 1B) revealed six diagnostic cases with VL exceeding the 5% positivity threshold recommended by the GFHC (5 ASMD A and 1 NPC).<span><sup>6</sup></span> VL exhibited a small number of empty vacuoles (ranging from 2 to 10) with regular contours, often clustered at one pole of the cell (morula-like) or aligned in a manner reminiscent of pearls on a string; they were rarely found in isolation (Figure 1B). In two cases, associated BM smears were analyzed, and only one showed vacuolated cells, including lymphocytes (Figure 1A case 5). No VL was identified in less severe forms at diagnosis (ASMD AB, B and later-onset NPC) or in patients followed at a distance from diagnosis (ASMD AB under enzyme replacement therapy (ERT) [<i>n</i> = 2 siblings], ASMD B ERT treated [<i>n</i> = 4] or untreated [<i>n</i> = 3], and NPC treated [<i>n</i> = 3]).</p><p>When splenomegaly and/or cytopenia are detected, a BM examination is often scheduled. Cytological analysis of BM and PB smears provides valuable information for diagnosing hematological disorders and aids in identifying certain rare LSD. Abnormal accumulation of metabolic by-products within lysosomes may result in the observation of storage cells (large histiocytic storage cells or VL) in BM and PB smears, as well as in prenatal effusions.<span><sup>7</sup></span> Identifying these storage cells can be challenging for untrained observers, as they may resemble storage cells from other LSD or appear similar to reactive cells.</p><p>In BM samples, the primary lesion was characterized by variable proportions of FH and, occasionally, SBH, as described in the literature.<span><sup>1, 9</sup></span> Despite the limited number of cases studied, SBH were primarily identified in patients with ASMD B and one patient with ASMD AB (Table 1A patient 10). SBH were not exclusive and were consistently found in conjunction with non-blue FH. This distinctive cytological appearance is also observed in various other LSD, including gangliosides, ceroid lipofuscinosis, and acquired diseases such as hemoglobinopathies (thalassemia, sickle cell anemia), neoplasms (chronic myeloid leukemia, lymphoma), immunological disorders (idiopathic thrombocytopenic purpura, chronic septic granulomatosis), or lipid storage disorders (SBH syndrome, parenteral nutrition). Interestingly, in patients 2 and 3, the presence of FH guided the diagnosis of LSD in the context of splenomegaly. In these two cases, the NPC biomarker profile was abnormal, but genetic testing did not confirm the diagnosis of NPC. Both patients were found to be compound heterozygous for a pathogenic or likely pathogenic variant and a variant of uncertain significance in the <i>NPC1</i> gene. The clinical significance of variants <i>NPC1</i>:p.Asn222Ser and p.Ser1004Leu is currently debated in the literature and among experts (see ClinVar database). However, these two cases illustrate that such variants, when combined with a pathogenic or likely pathogenic variant, may be associated with hematological manifestations. The densities of SBH and FH were variable and did not correlate with age; this variation appeared to be more related to the cell density of the smear.</p><p>Moreover, analysis of the BM smears revealed that approximately 50% of them exhibited a high lipid content, accompanied by a multitude of adipose vacuoles. No correlation was identified between the patient's lipid profile (when available), age, or disease type, and the proportion of lipid-laden histiocytes. This aspect was more closely related to the quality of the slides, as those that were diluted were less lipid-rich. Cytopenias, particularly thrombocytopenia, are common in patients with ASMD or NPC.<span><sup>1, 5, 10</sup></span> A review of complete blood count results revealed no correlation between the depth or presence of cytopenias and the proportion of BM infiltration by storage histiocytes.</p><p>In PB, VL is not often described in ASMD patients, contrary to NPC or other LSD.<span><sup>11</sup></span> Interestingly, only neurological forms of ASMD (type A) and NPC presented VL in our series. To our knowledge, no cases of ASMD B with VL in PB have been reported in the literature. Distinguishing these VL from reactive lymphocytes present in PB during an infectious episode is crucial.<span><sup>12</sup></span> The latter also display cytoplasmic microvacuoles, which can be observed as a small number of dispersed, fine vacuoles (ranging from one to three in number), or as a multitude of very fine vacuoles, irregularly distributed throughout the cytoplasm, with no discernible order or structure.</p><p>In conclusion, an increased number of FH with white and/or pale blue inclusions is a feature of BM smears in all types of ASMD/NPC. The detection of these FH (which is not limited to SBH alone) represents a significant advancement in the cytological diagnostic approach to ASMD/NPC. The identification of SBH strongly suggests an ASMD type B diagnosis, which requires confirmation by enzymatic activity measurement in combination with <i>SMPD1</i> gene analysis. In contrast, the presence of circulating VL in both PB and BM is uncommon in ASMD and NPC cases. Their presence should prompt consideration of a LSD, particularly a severe form with neurological involvement such as ASMD A or infantile NPC forms. This study represents the largest case series to date, and the results are noteworthy. Further investigation is required in a large prospective study. Finally, a meticulous examination of BM and PB smears is an essential tool to assist in the diagnosis of ASMD and NPC. This analysis is a valuable tool that can help define the different types of ASMD, in addition to the clinical examination and molecular analysis.</p><p>Sandrine Girard and Lucile Baseggio were involved in conceptualization, methodology, collecting data, analysis data, and writing of the original draft preparation. Sandrine Girard, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Catherine Trichet provided cases. Sandrine Girard, Mélanie Pannetier, Roseline Froissart, Cécile Pagan, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Lucile Baseggio were involved in reviewing the manuscript.</p><p>The authors declare no conflict of interest.</p><p>The study was approved by the Biological Resources Center policy of the Hospices Civils de Lyon. The procedures followed were in accordance with the Declaration of Helsinki. The protocol received approval from the institutional review board (DC-24-5447) This manuscript respects the ethical policy of Hospices Civils de Lyon for the treatment of human research participants. The authors did not obtain written informed consent from the patients but the patients did not object to their data being used for research purposes (as required by the ethics policy of Hospices Civils de Lyon).</p><p>This research received no funding.</p>\",\"PeriodicalId\":12982,\"journal\":{\"name\":\"HemaSphere\",\"volume\":\"8 11\",\"pages\":\"\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2024-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538321/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HemaSphere\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hem3.70042\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HemaSphere","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hem3.70042","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

溶酶体贮积病(LSD)是以溶酶体酶、转运体或辅助因子缺陷为特征的先天性代谢异常疾病。尼曼-皮克病分为两种不同的疾病:酸性鞘磷脂酶缺乏症(ASMD),历史上称为尼曼-皮克病 A、AB 和 B 型,以及尼曼-皮克病 C 型(NPC)。1 ASMD 是一种罕见的常染色体隐性遗传 LSD,由编码 ASM 的 SMPD1 基因(OMIM#607608)中的致病变体引起。2 ASMD 会导致鞘磷脂和其他脂质的积聚,主要积聚在肝、脾、肺、骨髓、淋巴结和中枢神经系统中。根据其临床表型,已报道有三种不同的亚型:A 型(严重的婴儿神经内脏型)、AB 型(慢性神经内脏型)和 B 型(慢性内脏型),具有连续谱。1-4 NPC 是一种常染色体隐性 LSD,由 NPC1 或 NPC2 两种蛋白之一的功能缺陷引起。它是由相应基因(OMIM#257220 和 OMIM#607625)的突变引起的。这两种蛋白依次调节内吞的非酯化胆固醇从晚期内体/溶酶体区室排出。5 NPC 的预后与神经系统症状的发病年龄相关,有四种神经系统形式:早期婴儿型、晚期婴儿型、青少年型和青少年-成人型。ASMD 和鼻咽癌的诊断比较困难,因为这些疾病具有异质性,可能与其他 LSD(如戈谢病)具有相同的临床特征,尤其是在出现脾肿大时。有报道称,ASMD 和鼻咽癌患者的骨髓(BM)和外周血(PB)涂片存在一些细胞学异常,这有助于指导更具体的分析,如酶活性、生物标志物测定和基因检测。本研究旨在报告一项回顾性研究中 30 例法国病例的 BM 和 PB 细胞学特征,这些病例来自 28 个 ASMD A 型 [n = 5]、AB 型 [n = 3]、B 型 [n = 16] 和 NPC 型 [n = 6]的家族、7 在 30 例病例中,18 例在诊断时进行了分析(10 例 BM 并伴有相应的 PB,4 例仅有 BM,4 例仅有 PB),12 例在随访期间进行了分析,其中包括 9 例接受过治疗的患者(11 例 PB 和 1 例 BM 并伴有相应的 PB)。ASMD A 诊断时的中位年龄为 8 个月(范围为 6.0-13.0),ASMD AB 为 18.0 岁,ASMD B 为 53 岁(范围为 20-87.0 个月),NPC 为 11.0 岁(范围为 2.0-17.0)。两名经验丰富的细胞学专家(SG、LB)在双盲条件下使用光学显微镜,在用 May Grünwald-Giemsa 染色后,对 BM 和 PB 涂片的细胞学特征进行了审查。他们评估了白细胞和组织细胞/巨噬细胞的特征以及造血组织的形态。对 14 份确诊的 BM 涂片(表 1A 和图 1A)进行检查后发现,所有病例(ASMD 和 NPC)中都有大量泡沫组织细胞(FH),这些组织细胞经常聚集在一起,有时也孤立存在。它们的核呈圆形或椭圆形,偶尔偏心,很少双核。细胞质丰富,含有许多大小不一的白色小空泡,呈蓝色或粉红色。在一些病例中,还观察到包膜和带有铁沉积物或碎屑(类似黑色或深蓝色小珠子)的组织细胞。7 例病例出现海蓝色组织细胞(SBH),主要是 ASMD B,1 例为 ASMD AB(图 1Aa)。在 3 个病例中观察到造血细胞空泡化,其中 1 个病例的 PB 中也出现了空泡化的淋巴细胞(VL)(图 1Ab)。在 6 个病例中,涂片中脂肪空泡较多,或在造血组织中观察到脂肪包裹体(图 1Ac)。对 26 份肺涂片(诊断时 14 份,随访时 12 份)(表 1A、B 和图 1B)的检查发现,6 例诊断病例的 VL 阳性率超过了 GFHC 建议的 5%阈值(5 例 ASMD A 和 1 例 NPC)。 6 VL 表现为少量空泡(2 至 10 个不等),轮廓规则,通常聚集在细胞的一极(鹅口疮样)或排列成珍珠串状;它们很少单独出现(图 1B)。在两个病例中,对相关的骨髓涂片进行了分析,只有一个病例出现了空泡细胞,包括淋巴细胞(图 1A 病例 5)。在诊断时病情较轻的患者(ASMD AB、B 和后来发病的 NPC)或距诊断较远的随访患者(ASMD AB 接受酶替代疗法(ERT)治疗[n = 2 个兄弟姐妹],ASMD B 接受 ERT 治疗[n = 4]或未接受治疗[n = 3],NPC 接受治疗[n = 3])中均未发现 VL。对骨髓和肺涂片进行细胞学分析可为诊断血液病提供有价值的信息,并有助于鉴别某些罕见的 LSD。溶酶体内代谢副产物的异常积聚可能导致在 BM 和 PB 涂片以及产前渗出液中观察到贮存细胞(大组织细胞贮存细胞或 VL)。对于未经训练的观察者来说,识别这些储存细胞可能具有挑战性,因为它们可能与其他 LSD 的储存细胞相似,或者看起来与反应性细胞相似。在 BM 样本中,原发病变的特征是 FH 比例不一,偶尔也会出现 SBH,这在文献中已有描述。SBH 并非唯一,而且一直与非蓝色 FH 同时发现。这种独特的细胞学外观也可见于其他各种 LSD,包括神经节苷脂、类脑脂质沉着病和后天性疾病,如血红蛋白病(地中海贫血、镰状细胞贫血)、肿瘤(慢性粒细胞白血病、淋巴瘤)、免疫性疾病(特发性血小板减少性紫癜、慢性化脓性肉芽肿)或脂质贮存障碍(SBH 综合征、肠外营养)。有趣的是,在患者 2 和 3 中,FH 的存在引导了脾肿大背景下的 LSD 诊断。在这两个病例中,鼻咽癌生物标志物特征异常,但基因检测并未确诊鼻咽癌。这两名患者都被发现是NPC1基因中一个致病或可能致病变体和一个意义不明变体的复合杂合子。目前,文献和专家们对变异体 NPC1:p.Asn222Ser 和 p.Ser1004Leu 的临床意义还存在争议(见 ClinVar 数据库)。不过,这两个病例说明,当这些变异与致病变异或可能致病的变异结合在一起时,可能与血液病表现有关。SBH和FH的密度变化不定,与年龄无关;这种变化似乎与涂片的细胞密度更相关。此外,对骨髓涂片的分析表明,约50%的涂片显示脂质含量高,并伴有大量脂肪空泡。患者的血脂情况(如有)、年龄或疾病类型与含脂组织细胞的比例之间没有相关性。这方面与切片的质量关系更为密切,因为稀释的切片脂质含量较少。细胞减少症,尤其是血小板减少症,在 ASMD 或鼻咽癌患者中很常见。1, 5, 10 全血细胞计数结果显示,细胞减少症的深度或存在与储能组织细胞浸润 BM 的比例之间没有相关性。据我们所知,文献中还没有 ASMD B 型患者在 PB 中出现 VL 的报道。将这些 VL 与感染发作期间出现在肺泡中的反应性淋巴细胞区分开来至关重要12。后者也显示细胞质微空泡,可观察到少量分散的细小空泡(数量从一个到三个不等),或大量非常细小的空泡,不规则地分布在整个细胞质中,没有明显的顺序或结构。总之,在所有类型的 ASMD/NPC 中,带有白色和/或淡蓝色内含物的 FH 数量增加是 BM 涂片的一个特征。检测这些FH(不仅限于SBH)是ASMD/NPC细胞学诊断方法的一大进步。SBH 的鉴定强烈提示了 ASMD B 型的诊断,这需要结合 SMPD1 基因分析,通过酶活性测定来确认。相反,在 ASMD 和鼻咽癌病例中,PB 和 BM 中出现循环 VL 的情况并不常见。它们的出现应引起对 LSD 的考虑,尤其是神经系统受累的严重类型,如 ASMD A 或婴儿型鼻咽癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann–Pick disease type C from bone marrow and peripheral blood smears

Lysosomal storage diseases (LSD) are inborn errors of metabolism disorders characterized by a defect in a lysosomal enzyme, transporter, or cofactor. Niemann–Pick diseases are classified into two distinct disorders: acid sphingomyelinase deficiency (ASMD) historically known as Niemann–Pick disease types A, AB, and B, and Niemann-Pick disease type C (NPC).1 ASMD is a rare autosomal recessive LSD, caused by pathogenic variants in the ASM-encoding SMPD1 gene (OMIM#607608).2 It results in the accumulation of sphingomyelin and other lipids, primarily in the liver, spleen, lung, bone marrow, lymph nodes, and central nervous system.3 Depending on their clinical phenotype, three different subtypes have been reported: A (severe infantile neurovisceral form), AB (chronic neurovisceral form), and B (chronic visceral form), with a continuum spectrum.1-4 NPC is an autosomal recessive LSD caused by the defective function of one of two proteins, NPC1 or NPC2. It results from mutations in the corresponding genes (OMIM#257220 and OMIM#607625). These two proteins act in sequence to regulate the egress of endocytosed nonesterified cholesterol from the late endosomal/lysosomal compartment. NPC manifests as a neurovisceral disease with a highly heterogeneous clinical spectrum.5 The prognosis of NPC is correlated with the age of onset of neurological symptoms, with four neurological forms defined: early infantile, late infantile, juvenile, and adolescent-adult. The diagnosis of ASMD and NPC is difficult because these diseases are heterogeneous and may share clinical features with other LSD such as Gaucher disease, especially when splenomegaly is present.5 Some cytological abnormalities have been reported in bone marrow (BM) and peripheral blood (PB) smears from ASMD and NPC patients, which could help to guide the more specific analysis such as enzymatic activity, biomarkers measurement, and genetic testing.6 However, the cytological data available in the literature are rather limited, often described in single case reports, and do not distinguish the different forms of ASMD and NPC. This work aims to report the cytological features of BM and PB in a retrospective study of 30 French cases from 28 families with ASMD types A [n = 5], AB [n = 3], B [n = 16], and NPC [n = 6], to improve knowledge and define recommendations to assist in diagnosis.

The diagnosis of cases was based on biochemical analysis, specifically either a deficiency in acid sphingomyelinase activity in blood and/or an abnormal plasma biomarkers profile (i.e., lysosphingomyelin, lysosphingomyelin509/N-palmitoyl-O-phosphocholineserine, and oxysterols), confirmed by specific gene analysis, except for two suspected NPC patients for whom the genetic study was inconclusive and identified a variant of uncertain significance.7 Of the 30 cases, 18 were analyzed at diagnosis (10 BM with corresponding PB, 4 BM only, and 4 PB only) and 12 during follow-up, including 9 treated patients (11 PB and 1 BM with corresponding PB). The median age at diagnosis was 8 months (range 6.0–13.0) for ASMD A, 18.0 years for ASMD AB, 53 years (range 20–87.0 months) for ASMD B, and 11.0 years (range 2.0–17.0) for NPC. The male-to-female ratios is 2:3, 1:0, 8:1, and 3:0, respectively.

Two experienced cytologists (SG, LB) reviewed the cytological features of BM and PB smears following staining with May Grünwald-Giemsa under double-blind conditions using a light microscope. They assessed leukocyte and histiocyte/macrophage characteristics as well as the pattern of the hematopoietic tissue.

Examination of 14 diagnostic BM smears (Table 1A and Figure 1A) revealed numerous foamy histiocytes (FH) in all cases (ASMD and NPC) often clustered and sometimes isolated. Their nuclei were round or oval, occasionally eccentric, and rarely bi-nucleated. The cytoplasm was abundant, containing numerous small white vacuoles of various sizes, which were highlighted in blue or pink. In some cases, emperipolesis and histiocytes with iron deposits or debris (resembling small black or dark blue beads) were observed. Seven cases exhibited sea-blue histiocytes (SBH), predominantly ASMD B and one in ASMD AB (Figure 1Aa). Vacuolization of hematopoietic cells was observed in three cases, including one case in which vacuolated lymphocytes (VL) were also present in PB (Figure 1Ab). In six cases, adipose vacuoles were more numerous in the spreads, or fatty inclusions were observed in the hematopoietic tissue (Figure 1Ac). Qualitative abnormalities such as dysmyelopoiesis were not noted.

Examination of 26 PB smears (14 at diagnosis and 12 at follow-up) (Tables 1A,B and Figure 1B) revealed six diagnostic cases with VL exceeding the 5% positivity threshold recommended by the GFHC (5 ASMD A and 1 NPC).6 VL exhibited a small number of empty vacuoles (ranging from 2 to 10) with regular contours, often clustered at one pole of the cell (morula-like) or aligned in a manner reminiscent of pearls on a string; they were rarely found in isolation (Figure 1B). In two cases, associated BM smears were analyzed, and only one showed vacuolated cells, including lymphocytes (Figure 1A case 5). No VL was identified in less severe forms at diagnosis (ASMD AB, B and later-onset NPC) or in patients followed at a distance from diagnosis (ASMD AB under enzyme replacement therapy (ERT) [n = 2 siblings], ASMD B ERT treated [n = 4] or untreated [n = 3], and NPC treated [n = 3]).

When splenomegaly and/or cytopenia are detected, a BM examination is often scheduled. Cytological analysis of BM and PB smears provides valuable information for diagnosing hematological disorders and aids in identifying certain rare LSD. Abnormal accumulation of metabolic by-products within lysosomes may result in the observation of storage cells (large histiocytic storage cells or VL) in BM and PB smears, as well as in prenatal effusions.7 Identifying these storage cells can be challenging for untrained observers, as they may resemble storage cells from other LSD or appear similar to reactive cells.

In BM samples, the primary lesion was characterized by variable proportions of FH and, occasionally, SBH, as described in the literature.1, 9 Despite the limited number of cases studied, SBH were primarily identified in patients with ASMD B and one patient with ASMD AB (Table 1A patient 10). SBH were not exclusive and were consistently found in conjunction with non-blue FH. This distinctive cytological appearance is also observed in various other LSD, including gangliosides, ceroid lipofuscinosis, and acquired diseases such as hemoglobinopathies (thalassemia, sickle cell anemia), neoplasms (chronic myeloid leukemia, lymphoma), immunological disorders (idiopathic thrombocytopenic purpura, chronic septic granulomatosis), or lipid storage disorders (SBH syndrome, parenteral nutrition). Interestingly, in patients 2 and 3, the presence of FH guided the diagnosis of LSD in the context of splenomegaly. In these two cases, the NPC biomarker profile was abnormal, but genetic testing did not confirm the diagnosis of NPC. Both patients were found to be compound heterozygous for a pathogenic or likely pathogenic variant and a variant of uncertain significance in the NPC1 gene. The clinical significance of variants NPC1:p.Asn222Ser and p.Ser1004Leu is currently debated in the literature and among experts (see ClinVar database). However, these two cases illustrate that such variants, when combined with a pathogenic or likely pathogenic variant, may be associated with hematological manifestations. The densities of SBH and FH were variable and did not correlate with age; this variation appeared to be more related to the cell density of the smear.

Moreover, analysis of the BM smears revealed that approximately 50% of them exhibited a high lipid content, accompanied by a multitude of adipose vacuoles. No correlation was identified between the patient's lipid profile (when available), age, or disease type, and the proportion of lipid-laden histiocytes. This aspect was more closely related to the quality of the slides, as those that were diluted were less lipid-rich. Cytopenias, particularly thrombocytopenia, are common in patients with ASMD or NPC.1, 5, 10 A review of complete blood count results revealed no correlation between the depth or presence of cytopenias and the proportion of BM infiltration by storage histiocytes.

In PB, VL is not often described in ASMD patients, contrary to NPC or other LSD.11 Interestingly, only neurological forms of ASMD (type A) and NPC presented VL in our series. To our knowledge, no cases of ASMD B with VL in PB have been reported in the literature. Distinguishing these VL from reactive lymphocytes present in PB during an infectious episode is crucial.12 The latter also display cytoplasmic microvacuoles, which can be observed as a small number of dispersed, fine vacuoles (ranging from one to three in number), or as a multitude of very fine vacuoles, irregularly distributed throughout the cytoplasm, with no discernible order or structure.

In conclusion, an increased number of FH with white and/or pale blue inclusions is a feature of BM smears in all types of ASMD/NPC. The detection of these FH (which is not limited to SBH alone) represents a significant advancement in the cytological diagnostic approach to ASMD/NPC. The identification of SBH strongly suggests an ASMD type B diagnosis, which requires confirmation by enzymatic activity measurement in combination with SMPD1 gene analysis. In contrast, the presence of circulating VL in both PB and BM is uncommon in ASMD and NPC cases. Their presence should prompt consideration of a LSD, particularly a severe form with neurological involvement such as ASMD A or infantile NPC forms. This study represents the largest case series to date, and the results are noteworthy. Further investigation is required in a large prospective study. Finally, a meticulous examination of BM and PB smears is an essential tool to assist in the diagnosis of ASMD and NPC. This analysis is a valuable tool that can help define the different types of ASMD, in addition to the clinical examination and molecular analysis.

Sandrine Girard and Lucile Baseggio were involved in conceptualization, methodology, collecting data, analysis data, and writing of the original draft preparation. Sandrine Girard, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Catherine Trichet provided cases. Sandrine Girard, Mélanie Pannetier, Roseline Froissart, Cécile Pagan, Thomas Boyer, Stephanie Dulucq, Valérie Gonçalves Monteiro, Nicolas Lechevalier, Marie Loosveld, Camille Lours, Caroline Mayeur-Rousse, Mélanie Pannetier, Caroline Peillon, Maria-Alessandra Rosenthal, Sonnthida Sep Hieng, Lucile Baseggio were involved in reviewing the manuscript.

The authors declare no conflict of interest.

The study was approved by the Biological Resources Center policy of the Hospices Civils de Lyon. The procedures followed were in accordance with the Declaration of Helsinki. The protocol received approval from the institutional review board (DC-24-5447) This manuscript respects the ethical policy of Hospices Civils de Lyon for the treatment of human research participants. The authors did not obtain written informed consent from the patients but the patients did not object to their data being used for research purposes (as required by the ethics policy of Hospices Civils de Lyon).

This research received no funding.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
HemaSphere
HemaSphere Medicine-Hematology
CiteScore
6.10
自引率
4.50%
发文量
2776
审稿时长
7 weeks
期刊介绍: HemaSphere, as a publication, is dedicated to disseminating the outcomes of profoundly pertinent basic, translational, and clinical research endeavors within the field of hematology. The journal actively seeks robust studies that unveil novel discoveries with significant ramifications for hematology. In addition to original research, HemaSphere features review articles and guideline articles that furnish lucid synopses and discussions of emerging developments, along with recommendations for patient care. Positioned as the foremost resource in hematology, HemaSphere augments its offerings with specialized sections like HemaTopics and HemaPolicy. These segments engender insightful dialogues covering a spectrum of hematology-related topics, including digestible summaries of pivotal articles, updates on new therapies, deliberations on European policy matters, and other noteworthy news items within the field. Steering the course of HemaSphere are Editor in Chief Jan Cools and Deputy Editor in Chief Claire Harrison, alongside the guidance of an esteemed Editorial Board comprising international luminaries in both research and clinical realms, each representing diverse areas of hematologic expertise.
期刊最新文献
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial The incidence and clinical significance of monoclonal and oligoclonal protein bands in multiple myeloma patients after BCMA–CAR-T cell therapy: A retrospective study based on LEGEND-2 Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study A single-chain variable fragment-based bispecific T-cell activating antibody against CD117 enables T-cell mediated lysis of acute myeloid leukemia and hematopoietic stem and progenitor cells IL-11—An aging-related cytokine with opportunities for regulating hematopoiesis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1